Posts filed under "Corporate Concentration"

Jolly gene giant-a book review of Claire Hope Cummings’ “Uncertain Peril”

Tuesday, May 6th, 2008

Review by Hope Shand, research director of ETC Group.

In October 1996, a spokesman for Monsanto told Farm Journal why his company was buying up seed companies left and right: “What you’re seeing is not just a consolidation of seed companies, it’s really a consolidation of the entire food chain.”

Today, Monsanto is the world’s largest seed […]

Read the rest of this entry

Meanwhile back in Corporate Synbioville…

Wednesday, June 27th, 2007

The BP-Berkeley deal, the new joint Bio Energy institute, and also the recent job hop by John Menlo of BP fuels to Amyris Biotech - are all extra strings tying the interests of the Syn Bio community as a wholeever closer to the interests of big business. It should be noted that in each of thse cases CEO Keasling plays a central role. The same man who claims to be developing Synthetic Biology to serve the worlds poor (via synthetic artemisinin) seems to be rather busy these days serving the fabulously rich.

Read the rest of this entry

Terminator: The Sequel — A New and More Dangerous Generation of Suicide Seeds Unveiled

Sunday, June 17th, 2007

When patents on Terminator seeds first came to light nine years ago, even the most jaded among us were stunned by the audacious corporate greed manifested by this novel (and complex) gene engineering technique. Terminator refers to crops that are genetically modified to render sterile seeds at harvest – the equivalent of a “biological patent” […]

Read the rest of this entry

In Vivo, In Vitro, In Venter…?

Friday, June 8th, 2007

Is Craig Venter, the so called “bad boy of biology”, about to announce the world’s first synthetic lifeform? (or ‘Syn’ for short)… we don’t know. According to New Scientist “rumours are circulating that his institute will soon unveil the first synthetic bacterium”. What we do know is that he has applied for a patent with broad claims that include a synthetic organism itself…

Read the rest of this entry

Monsanto’s Takeover of D&PL: The Nail’s in the Coffin

Tuesday, June 5th, 2007

Last week the US Justice Department (DOJ) gave the green light for Monsanto’s $1.5 billion takeover of the world’s largest cotton seed company, Delta & Pine Land (D&PL) — the company that has long vowed to commercialize Terminator seeds (more on that below). The so-called “anti-trust” regulators approved the deal with […]

Read the rest of this entry

Further Reflections on EPO Decision to REVOKE Monsanto’s Transgenic Soybean Patent

Wednesday, May 9th, 2007

Further reflections on EPO’s May 3 decision to revoke Monsanto’s species-wide soybean patent ETC Group has been receiving lots of emails and phone calls in the past few days about the defeat of Monsanto’s soybean patent one week ago. While most have been congratulatory a few have asked whether this wasn’t in fact a hollow victory […]

Read the rest of this entry

Top Ten Seed Companies 2007

Monday, April 30th, 2007

In a couple of days Hope Shand from ETC Group will be in court in the European patent Office to challenge Monsanto’s Patent on Soy beans - a patent that we have been contesting for 13 years and that originally Monsanto themselves opposed!! You can read more about that here. In the meantime, ETC […]

Read the rest of this entry

5-4-3-2-1! GM Crop Countdown.

Thursday, April 26th, 2007

The biotech industry claims that the global area devoted to GM crops in 2005 was 90 million hectares - or 222 million acres. ETC Group does not endorse or agree with the validity of annual statistics on GM crops compiled by the International Service for the Acquisition of Agri-biotech Applications (ISAAA).

We agree with civil society critics who charge that ISAAA’s statistics are inflated and unreliable. However, even using industry-generated statistics, the biotech countdown is revealing. Here are the “vital statistics”:

Read the rest of this entry

2006 and the plutocracy

Monday, February 26th, 2007

In this article the author makes a very enlightening summary of corporate concentration during 2006, and how this affects our lives as simple citizens even though we think it’s something happening far away…

by Silvia Ribeiro

Corporate concentration through global mergers and acquisitions reached a record at the close of 2006. In our daily life this […]

Read the rest of this entry

Nano-Drug’s Dirty Little Secret

Friday, October 6th, 2006

Nano-Drug’s Dirty Little Secret

ETC Group’s September 2006 report on nanomedicine, Nanotech Rx, requires some updating. After all, it’s nearly 30 days old. Our report mentions the nano-drug Abraxane, and it acknowledges that approval of the cancer drug was a watershed event for the nanotech industry. But important details are emerging. On October 1 the […]

Read the rest of this entry